miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27kip1 expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27kip1 expression

Published:2016-09 Issue:1 Volume:590 Page:44-50
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Wang Dan-dan,Li Jian,Sha Huan-huan,Chen Xiu,Yang Su-jin,Shen Hong-Yu,Zhong Shan-liang,Zhao Jian-hua,Tang Jin-hai

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference23 articles.

1. miR-221/222: promising biomarkers for breast cancer;Chen;Tumour Biol.: the journal of the International Society for Oncodevelopmental Biology and Medicine,2013

2. SPLUNC1 regulates cell progression and apoptosis through the miR-141-PTEN/p27 pathway, but is hindered by LMP1;Chen;PLoS One,2013

3. MicroRNA-200b stimulates tumour growth in TGFBR2-null colorectal cancers by negatively regulating p27/kip1;Fu;J. Cell. Physiol.,2014

4. Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3;Gan;Cancer Gene Ther.,2014

5. MicroRNA miR-24 promotes cell proliferation by targeting the CDKs inhibitors p27Kip1 and p16INK4a;Giglio;J. Cell. Physiol.,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulatory effects of miRNAs in doxorubicin resistance: A mechanistic view;Functional & Integrative Genomics;2024-09-02

2. The Role of miRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review;Frontiers in Oncology;2022-05-12

3. Regulation of CDK inhibitor p27 by microRNA 222 in breast cancer patients;Experimental and Molecular Pathology;2021-12

4. Changes in miR-222 expression, DNA repair capacity, and MDM2-p53 axis in association with low-dose benzene genotoxicity and hematotoxicity;Science of The Total Environment;2021-04

5. Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment;Journal of Mammary Gland Biology and Neoplasia;2021-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3